ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이오슬랙스 시장 규모는 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 생물 테러에 대한 우려 증가, 정부 국방비 증가, 전 세계 생물 방어 프로그램의 확대, 백신 기술의 발전, 공중 보건 준비 이니셔티브의 확대에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 정부 및 군사 투자 증가, 생물 방어 이니셔티브 확대, 백신 전달 시스템 개선, 생물 테러 위험에 대한 인식 제고, 전략적 파트너십 및 협력 등이 있습니다.
육류 소비의 증가는 바이오슬랙스 시장의 성장을 촉진할 것으로 예상됩니다. 육류 소비는 도시화, 소득 수준 상승, 식습관의 변화, 육류를 단백질과 영양의 주요 공급원으로 강조하는 문화적 전통과 같은 요인의 영향을 받습니다. 바이오슬랙스는 오염된 육류를 통해 전염될 수 있는 탄저병에 대한 가축의 예방 접종에 사용되어 육류 제품의 안전을 보장하고 동물원성 질병의 발생으로부터 공중 보건을 보호합니다. 예를 들어, 식량 농업 기구(FAO)는 전 세계 육류 생산량이 2021년 3억 5,690만 톤에서 2023년 3억 6,390만 톤으로 1.96% 증가할 것으로 보고했으며, 소고기 생산량은 2021년 7,490만 톤에서 2023년 7,610만 톤으로 증가할 것으로 전망했습니다. 따라서 육류 소비의 증가는 바이오슬랙스 시장의 성장을 촉진하고 있습니다.
탄저병의 유행이 증가하면서 바이오슬랙스 시장의 성장이 가속화될 것으로 예상됩니다. 탄저병은 주로 토양에서 발견되는 탄저균의 포자에 의해 발생합니다. 탄저병을 예방하는 백신인 바이오슬랙스는 면역계를 자극하여 탄저균에 대한 항체를 생성하도록 합니다. 예를 들어, 세계보건기구(WHO)에 따르면 2023년 11월 현재 잠비아에서는 4명의 사망자를 포함해 684명의 탄저병 의심 환자가 보고되었습니다. 탄저병의 유행으로 인해 이 질병을 퇴치하고 공중 보건을 보호하기 위한 백신의 필요성이 높아지고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여경로(ROA)
작용기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 바이오슬랙스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 바이오슬랙스 시장 : 성장률 분석
세계의 바이오슬랙스 시장 실적 : 규모와 성장(2019-2024년)
세계의 바이오슬랙스 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 바이오슬랙스 : 전체 시장 규모(TAM)
제7장 세계 시장의 가격 분석과 예측
제8장 시장 세분화
세계의 바이오슬랙스 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
생백신
무세포 보호 항원 백신
세계의 바이오슬랙스 시장 : 질환별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
노출 전 예방
노출 후 예방
세계의 바이오슬랙스 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
인간용
동물용
세계의 바이오슬랙스 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
백신 접종 센터
기타
제9장 임상적응증 세계 시장 역학
약제의 부작용
임상적응증의 발병률과 유병률
제10장 지역별, 국가별 분석
세계의 바이오슬랙스 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 바이오슬랙스 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 프로파일
바이오슬랙스 시장 : 경쟁 구도
바이오슬랙스 시장 : 기업 프로파일
Emergent Bio-Solutions
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 전략
바이오슬랙스 시장(2029년) : 새로운 기회를 제공하는 국가
바이오슬랙스 시장(2029년) : 새로운 기회를 제공하는 부문
바이오슬랙스 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
HBR
영문 목차
영문목차
Biothrax is a vaccine designed to protect against anthrax, a serious and potentially fatal illness caused by the bacterium Bacillus anthracis. The vaccine stimulates the immune system to produce antibodies against anthrax toxins, which can be lethal if exposure occurs, particularly in bioterrorism scenarios.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary types in the biothrax market are live vaccines and cell-free protective antigen vaccines. Live vaccines are made from weakened (attenuated) organisms that do not cause disease but effectively trigger a strong immune response. The clinical indications include pre-exposure prophylaxis and post-exposure prophylaxis. The vaccine is used for both human and animal applications, with end users including hospitals, clinics, vaccination centers, and others.
The biothrax market research report is one of a series of new reports from The Business Research Company that provides biothrax market statistics, including biothrax industry global market size, regional shares, competitors with a biothrax market share, detailed biothrax market segments, market trends, and opportunities, and any further data you may need to thrive in the biothrax industry. This biothrax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biothrax market size is expected to see strong growth in the next few years. It will grow to $1,300 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to rising bioterrorism concerns, increased government defense spending, expansion of global biodefense programs, advancements in vaccine technology, growing public health preparedness initiatives. Major trends in the forecast period include increased government and military investments, expansion of biodefense initiatives, improvement in vaccine delivery systems, rising awareness of bioterrorism risks, strategic partnerships and collaborations.
Increasing consumption of meat is expected to drive the growth of the biothrax market. Meat consumption is influenced by factors such as urbanization, rising income levels, evolving dietary preferences, and cultural traditions that emphasize meat as a primary source of protein and nutrition. BioThrax is used to vaccinate livestock against anthrax, a disease that can spread through contaminated meat, ensuring the safety of meat products and protecting public health from zoonotic disease outbreaks. For instance, the Food and Agriculture Organization (FAO) reported a 1.96% increase in global meat production from 356.9 million metric tons in 2021 to 363.9 million metric tons in 2023, with bovine meat production rising from 74.9 million metric tons in 2021 to 76.1 million metric tons in 2023. Thus, the rising meat consumption is driving the growth of the biothrax market.
Growing prevalence of anthrax is expected to propel the growth of the biothrax market. Anthrax is primarily caused by Bacillus anthracis spores found in soil. BioThrax, a vaccine that helps prevent anthrax, stimulates the immune system to produce antibodies against Bacillus anthracis. For example, as of November 2023, Zambia reported 684 suspected human cases of anthrax, including four deaths, according to the World Health Organization (WHO). The prevalence of anthrax is driving the need for vaccines such as biothrax to combat the disease and protect public health.
A key trend in the biothrax market is the focus on strategic investments to enhance production capabilities, expand geographic presence, and develop advanced anthrax vaccines. Strategic funding supports clinical trials and regulatory compliance, allowing companies to gain approvals across multiple regions and expand vaccine availability to underserved areas. For instance, in January 2024, Emergent BioSolutions, a US-based biotech company, secured a contract worth up to $235.8 million from the U.S. Department of Defense (DoD) to supply BioThrax for military use. This contract highlights the continued demand for anthrax vaccines and underscores Emergent's long-standing relationship with the U.S. government in providing biodefense solutions.
Major players operating in the biothrax market are Emergent Bio-Solutions.
North America was the largest region in the biothrax market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biothrax report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biothrax market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biothrax market consists of sales of single-dose vials and multi-dose vials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biothrax Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biothrax market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biothrax ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biothrax market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Live Vaccines; Cell Free Protective Antigen Vaccines
2) By Clinical Indication: Pre-Exposure Prophylaxis; Post-Exposure Prophylaxis
3) By Application: Human Use; Animal Use
4) By End-User: Hospital; Clinics; Vaccination Centers; Other End-Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biothrax Market Characteristics
3. Biothrax Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Biothrax Market Trends And Strategies
5. Biothrax Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Biothrax Growth Analysis And Strategic Analysis Framework
6.1. Global Biothrax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Biothrax Market Growth Rate Analysis
6.4. Global Biothrax Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Biothrax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Biothrax Total Addressable Market (TAM)
7. Global Biothrax Market Pricing Analysis & Forecasts
8. Biothrax Market Segmentation
8.1. Global Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Vaccines
Cell Free Protective Antigen Vaccines
8.2. Global Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
8.3. Global Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Use
Animal Use
8.4. Global Biothrax Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Clinics
Vaccination Centers
Other End-Users
9. Global Biothrax Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Biothrax Market Regional And Country Analysis
10.1. Global Biothrax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Biothrax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Biothrax Market
11.1. Asia-Pacific Biothrax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Biothrax Market
12.1. China Biothrax Market Overview
12.2. China Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Biothrax Market
13.1. India Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Biothrax Market
14.1. Japan Biothrax Market Overview
14.2. Japan Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Biothrax Market
15.1. Australia Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Biothrax Market
16.1. South Korea Biothrax Market Overview
16.2. South Korea Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Biothrax Market
17.1. Western Europe Biothrax Market Overview
17.2. Western Europe Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Biothrax Market
18.1. UK Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Biothrax Market
19.1. Germany Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Biothrax Market
20.1. France Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biothrax Market
21.1. Eastern Europe Biothrax Market Overview
21.2. Eastern Europe Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Biothrax Market
22.1. North America Biothrax Market Overview
22.2. North America Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Biothrax Market
23.1. USA Biothrax Market Overview
23.2. USA Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Biothrax Market
24.1. Canada Biothrax Market Overview
24.2. Canada Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Biothrax Market
25.1. South America Biothrax Market Overview
25.2. South America Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Biothrax Market
26.1. Middle East Biothrax Market Overview
26.2. Middle East Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Biothrax Market
27.1. Africa Biothrax Market Overview
27.2. Africa Biothrax Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Biothrax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Biothrax Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Biothrax Market Competitive Landscape And Company Profiles
28.1. Biothrax Market Competitive Landscape
28.2. Biothrax Market Company Profiles
28.2.1. Emergent Bio-Solutions Overview, Products and Services, Strategy and Financial Analysis
29. Global Biothrax Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Biothrax Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Biothrax Market
32. Recent Developments In The Biothrax Market
33. Biothrax Market High Potential Countries, Segments and Strategies
33.1 Biothrax Market In 2029 - Countries Offering Most New Opportunities
33.2 Biothrax Market In 2029 - Segments Offering Most New Opportunities
